JOURNAL ARTICLE
Add like
Add dislike
Add to saved papers

Benign monomelic amyotrophies of upper and lower limb are not associated to deletions of survival motor neuron gene.

Benign monomelic amyotrophies (BMAs) are rare conditions in which neurogenic atrophy is restricted either to the upper or lower limb. BMAs are usually sporadic, have insidious onset and slow progression followed by stabilization, are clinically confined for many years to a single limb and lack of sensory, bulbar, and pyramidal signs. Although the aetiology and pathogenesis of BMAs are unknown they are considered variants of spinal muscular atrophy with focal emphasis and a benign course. We studied 7 patients with BMAs to investigate whether they present alterations of the survival motor neuron gene (SMN) which has been found deleted or disrupted in proximal spinal muscular atrophy. All 7 patients showed the presence of both exon 7 and 8 of SMN gene. These findings indicate that deletions at the SMN locus are not present in BMA of upper and lower limb and suggest that these disorders are not only clinically but also genetically separate entities from proximal spinal muscular atrophies.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app